CAR-CD19 T cell
CGZ001
Unknown gene_therapy active
Quick answer
CAR-CD19 T cell for B Cell Lymphoma is a Unknown program (gene_therapy) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- B Cell Lymphoma
- Phase
- Unknown
- Modality
- gene_therapy
- Status
- active